BIA
BCYC

Bell Investment Advisors’s Bicycle Therapeutics BCYC Stock Holding History

Bell Investment Advisors’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22
Closed -$187 – 1892
2025
Q1 		$187 Hold
22
– – ﹤0.01% 1869
2024
Q4 		$308 Hold
22
– – ﹤0.01% 1857
2024
Q3 		$498 Hold
22
– – ﹤0.01% 1780
2024
Q2 		$446 Buy
+22
New +$497 ﹤0.01% 1852
2023
Q4 		– Sell
-24
Closed -$483 – 1921
2023
Q3 		$483 Sell
24
-13
-35% -$297 ﹤0.01% 1808
2023
Q2 		$945 Buy
+37
New +$859 ﹤0.01% 1613

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Bell Investment Advisors's BCYC Position: Q2 2025 in Review

Bell Investment Advisors sold out of Bicycle Therapeutics (BCYC) in Q2 2025, closing a stake of 22 shares — an estimated $187 sold.

Bell Investment Advisors first reported a position in BCYC in Q2 2023 and held it in 6 quarters. The position peaked at $945 in Q2 2023. 110 funds tracked by Wall St. Rank hold BCYC as of Q2 2025.

  • Bell Investment Advisors reported no remaining Bicycle Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Bell Investment Advisors sold 22 Bicycle Therapeutics shares in Q2 2025, an estimated $187.
  • Bell Investment Advisors first reported a position in Bicycle Therapeutics in Q2 2023 and held it in 6 quarters.
  • Bell Investment Advisors's Bicycle Therapeutics position peaked at $945 in Q2 2023.
  • 110 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2025.

Based on Bell Investment Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.